Barclays
OCS icon

Barclays’s Oculis Holding OCS Stock Holding History

Barclays’s Portfolio OCS Stock Details OCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-3,602
Closed -$44.4K – 4671
2023
Q2 		$44.4K Buy
+3,602
New +$40.2K ﹤0.01% 3893

Other funds holding OCS

PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return
CLOS
Compagnie Lombard Odier SCmA 1204 Geneva, Switzerland $9.25B AUM 27.04% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
EC
Elequin Capital New York $1.19B AUM 16.08% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
DCM
Dupont Capital Management Wilmington, Delaware $2.18M AUM 50.81% 1-Year Est. Return

Barclays's OCS Position: Q3 2023 in Review

Barclays sold out of Oculis Holding (OCS) in Q3 2023, closing a stake of 3,602 shares — an estimated $44.4K sold.

Barclays first reported a position in OCS in Q2 2023 and held it in 1 quarter. The position peaked at $44.4K in Q2 2023. 9 funds tracked by Wall St. Rank hold OCS as of Q3 2023.

  • Barclays reported no remaining Oculis Holding position as of Q3 2023 after selling out during the quarter.
  • Barclays sold 3,602 Oculis Holding shares in Q3 2023, an estimated $44.4K.
  • Barclays first reported a position in Oculis Holding in Q2 2023 and held it in 1 quarter.
  • Barclays's Oculis Holding position peaked at $44.4K in Q2 2023.
  • 9 funds tracked by Wall St. Rank held Oculis Holding as of Q3 2023.

Based on Barclays's 13F filing for Q3 2023, filed 7 Nov 2023.